dexamethasone sodium phosphate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
DEXAMETHASONE VIATRIS dexamethasone phosphate (as dexamethasone sodium phosphate) 4mg/1mL solution for injection vial AUST R: 163200Active ingredients:
dexamethasone sodium phosphate
Dosage form:
Injection
Sponsor:
Alphapharm Pty Ltd
Phone:
1800 274 276
|
From
01 Jun 2022
to
30 Nov 2023
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Manufacturing
Management action:
An unregistered product has been approved for supply under Section 19A. The approval holder, Alphapharm Pty Ltd can be contacted on 1800 274 276 for details on supply.
|
DBL DEXAMETHASONE SODIUM PHOSPHATE INJECTION 4mg/1mL (as sodium) injection ampoule AUST R: 16374Active ingredients:
dexamethasone sodium phosphate
Dosage form:
Injection, solution
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800 675 229
|
Deletion from market:
01 May 2023
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
An alternate presentation of the same strength is available.
|